VP
Teva pharmaceuticals
Philadelphia, Pennsylvania, United States
Mehran Yazdanian is Vice President of R&D Operations at Teva Pharmaceuticals and the R&D Site Head for Teva’s West Chester, PA facility. He leads R&D activities for development of innovative biologicals and biosimilars from clone selection to regulatory submission.
He received his BS in biochemistry and MS and PhD in pharmaceutics from the University of Wisconsin-Madison. His career has been focused on directing formulation and analytical development activities from early drug discovery support and preformulation to formulation development. He has extensive experience in manufacturing for clinical programs and commercialization support for both small molecule and biological drug candidates.
Previously he led an integrated Pharmaceutics department at Cephalon comprised of analytical and formulation development scientists as well as manufacturing engineers supporting product development. Before that he headed the Physical Pharmaceutics section of the pharmaceutics department at Boehringer Ingelheim Pharmaceuticals Inc. His first job was at Merck Research Laboratories where he worked on formulation development of transdermal and liquid dosage forms for veterinary applications.
Mehran has lived in Philadelphia over the past 19 years where he is actively involved with helping students attending Community College of Philadelphia with access to food and ultimately success in their pursuit of higher education.
Disclosure information not submitted.
Monday, April 24, 2023
9:30 AM – 10:00 AM ET